Nicolas Correa SA (NEA)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 9.720 |
|---|---|
| 52-week range | 8.760 – 11.300 |
| Return, 1 month / 3 months | −5.6% / +3.4% |
| Return, 1 year / 3 years | −0.9% / +79.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -13.2% |
| Average daily value traded | 0.04M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nicolas Correa is a Spanish machine-tool maker based in Burgos that designs and builds milling machines and machining centres. Its range covers bridge-type and gantry milling machines, floor-type boring and milling machines, and other computer-controlled machine tools used to cut and shape metal parts. The company serves industrial customers in sectors such as energy, aerospace, railway and general engineering, supplying equipment for machining large and complex components. It sells its machines to manufacturers in Spain and in export markets around the world.
The shares are listed on the Madrid Exchange in Spain under the code NEA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nicolas Correa SA (NEA) trades on the Madrid Exchange in Spain. It last closed at EUR 9.720 on 22 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 93 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.9% and over the last three months it rose 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -8.3% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.4% | ||
| 6-month return | -4.2% | ||
| 12-month return, skipping the last month | 5.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.2% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.04M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −5.6% |
| 3 months | +3.4% |
| 6 months | −4.2% |
| 1 year | −0.9% |
| 3 years | +79.4% |
| 5 years | +85.8% |
Signals
| 50-day / 200-day average | 9.846 / 9.710 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.326 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | EUR 0.2430 |
| 5 Jun 2025 | EUR 0.2430 |
| 2 May 2024 | EUR 0.2187 |
| 4 May 2023 | EUR 0.1863 |
| 29 Apr 2022 | EUR 0.1620 |
| 7 May 2021 | EUR 0.1377 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.